XML 57 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information
3 Months Ended
Dec. 31, 2012
Segment Information
7.

SEGMENT INFORMATION

We report our continuing operations in three operating segments: Fine Chemicals, Specialty Chemicals, and Other Businesses. These segments are based upon business units that offer distinct products and services, are operationally managed separately and produce products using different production methods. Segment operating income or loss includes all sales and expenses directly associated with each segment. Environmental remediation charges, corporate general and administrative costs, which consist primarily of executive, investor relations, accounting, human resources and information technology expenses, and interest are not allocated to segment operating results.

Fine Chemicals. Our Fine Chemicals segment includes the operating results of our wholly-owned subsidiaries Ampac Fine Chemicals LLC and AMPAC Fine Chemicals Texas, LLC (collectively, “AFC”). AFC is a custom manufacturer of active pharmaceutical ingredients and registered intermediates for commercial customers in the pharmaceutical industry. AFC operates in compliance with the U.S. Food and Drug Administration’s current Good Manufacturing Practices and the requirements of certain other regulatory agencies such as the European Union’s European Medicines Agency and Japan’s Pharmaceuticals and Medical Devices Agency. AFC also complies with Drug Enforcement Administration requirements related to the manufacture and sale of certain controlled substances. AFC has distinctive competencies and specialized engineering capabilities in performing chiral separations, manufacturing chemical compounds that require high containment, performing energetic chemistries at commercial scale, and manufacturing Schedule II controlled substances.

Specialty Chemicals. Our Specialty Chemicals segment manufactures and sells: (i) perchlorate chemicals, principally ammonium perchlorate, which is the predominant oxidizing agent for solid propellant rockets, booster motors and missiles used in space exploration, commercial satellite transportation and national defense programs, (ii) sodium azide, a chemical used in pharmaceutical manufacturing, and (iii) Halotron®, a series of clean fire extinguishing agents used in fire extinguishing products ranging from portable fire extinguishers to total flooding systems.

Other Businesses. Our Other Businesses segment contains our water treatment equipment division and real estate activities. Our water treatment equipment business markets, designs, and manufactures electrochemical On Site Hypochlorite Generation, or OSHG, systems. These systems are used in the disinfection of drinking water, control of noxious odors, and the treatment of seawater to prevent the growth of marine organisms in cooling systems. We supply our equipment to municipal, industrial and offshore customers. Our real estate activities are not material.

Our revenues are characterized by individually significant orders and relatively few customers. As a result, in any given reporting period, certain customers may account for more than ten percent of our consolidated revenues. The following table provides disclosure of the percentage of our consolidated revenues from continuing operations attributed to customers that exceed ten percent of the total in each of the given periods.

 

                                 
 

 

 

 
    Three Months Ended  
    December 31,  
            2012                     2011          
 

 

 

 

Fine chemicals cust omer

    36%        32%     

Specialty chemicals customer

    30%        25%     

 

The following provides financial information about our segment operations:

 

                                                         
  

 

 

 
     Three Months Ended  
     December 31,  
     2012     2011  
  

 

 

 

Revenues:

    

Fine Chemicals

     $         21,347         $         21,475      

Specialty Chemicals

     14,350         14,220      

Other Businesses

     621         2,790      
  

 

 

 

Total Revenues

     $ 36,318         $ 38,485      
  

 

 

 

Segment Operating Income (Loss):

    

Fine Chemicals

     $ 1,277         $ (1,187)     

Specialty Chemicals

     7,917         7,644      

Other Businesses

     (160)        (72)     
  

 

 

 

Total Segment Operating Income (Loss)

     9,034         6,385      

Corporate Expenses

     (4,086)        (3,626)     
  

 

 

 

Operating Income

     $ 4,948         $ 2,759      
  

 

 

 

Depreciation and Amortization:

    

Fine Chemicals

     $ 3,015         $ 3,040      

Specialty Chemicals

     207         235      

Other Businesses

            4      

Corporate

     83         94      
  

 

 

 

Total Depreciation and Amortization

     $ 3,310         $ 3,373